NEW YORK (GenomeWeb News) — Proteome Sciences said today it will use its ProteoShop services to analyze diagnostic antibodies related to prostate and colon cancer for Onconome.
 
Under the agreement, Proteome Sciences will use its 2-D gel Western blotting technology to characterize Onconome’s antibodies, and will use its 2-D gel electrophoresis and Tandem Mass Tags for further analysis.  
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.